Book Value per Share: Ensysce Biosciences Inc. (ENSC)

Public company logo of Ensysce (ENSC)

Ensysce Biosciences (ENSC) is mitigating ESG risks by implementing bioethical compliance and zero-waste production methods. The target book value per share reflects net capital dynamics, with the metric currently standing at -0.05. Stability is ensured through diversified raw material supplies. The company's revenues are based on the sale of abuse-deterrent opioids to government agencies and patients with chronic pain.

Ensysce (ENSC) Equity per Share: for the period 07/04/2022 - 10/26/2026

Summary analytical data breakdowns for Ensysce Biosciences Inc. (ENSC)

- price and consensus price forecast:
Price Chart Ensysce|ENSC - Analyst Median Target
- market capitalization data:
Market Capitalization Ensysce Biosciences, Inc.|ENSC - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Ensysce Biosciences|ENSC - Accounting Capitalization|Market Capitalization to Book Value Ratio ensysce.com|ENSC - Company Total Assets
- debt and liquidity data:
Debt to Equity Ensysce Biosciences|ENSC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Ensysce|ENSC - Company Total Debt|Debt to Book Capitalization Ratio Ensysce Biosciences, Inc.
Fundamental company valuation:ensysce.com, ENSC
Signature product of Ensysce Biosciences Inc.

For an investor in Ensysce Biosciences (ENSC), the success of clinical trials to combat the opioid crisis is key, as it renders the business independent of macroeconomic cycles. The book value per share measures the portion of net assets in each security, reflecting the real value of capital minus liabilities. The trend in capital per share confirms the issuer's long-term financial stability.

Competitor analysis

Net Assets per Single Share INDV (Indivior Group)|COLL - Net Assets per Share|CRON (Cronos Group Inc.) - Book Value per Share|CGC (canopygrowth.com) - Accounting Value per Share|Net Assets per Single Share High Tide (HITI)|Equity per Share Aurora|Book Value per Share ACHV|Book Value per Share SKYE (Skye Bioscience Inc.)|Net Assets per Single Share Anebulo Pharmaceuticals|Accounting Value of a Share InterCure Ltd INCR|NTRB: Book Value per Share|NSRX: Accounting Value per Share|Net Assets per Single Share IGC|Net Asset Value per Share MIRA Pharmaceuticals, Inc.|FLGC - Accounting Value per Share|Accounting Value of a Share IMC|ADIL - Book Value per Share|Share Book Value artelobio.com (ARTL)|Book Value per Share TTNP (Titan Pharmaceuticals, Inc.)|Greenlane Corp - Book Value per Share|Net Assets per Single Share InMed Pharmaceuticals (INM)|AKAN: Accounting Value of a Share|ENVB (Enveric Biosciences, Inc.) - Net Assets per Single Share|Bright Green Corporation (BGXX) - Accounting Value per Share|Book Value per Share HPCO (Hempacco Co., Inc.)